LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 7 of 15: Mean cell count and mean growth rate across all replicates. - Dataset (ID:20243)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Mean Relative Cell Count Standard Error of the Mean for Relative Cell Count Mean Relative Growth Rate Standard Error of the Mean for Relative Growth Rate
BT-20 GSK1059615
0.04
uM
LJP5
 1.0055 0.0228 1.0092 0.0334
BT-20 GSK1059615
0.04
uM
LJP6
 0.8839 0.0449 0.8343 0.0627
BT-20 GSK1904529A
0.04
uM
LJP6
 0.8394 0.0192 0.7668 0.0304
BT-20 Omipalisib
0.04
uM
LJP6
 0.2655 0.0296 -0.0633 0.0312
BT-20 GSK 690693
0.04
uM
LJP5
 0.8635 0.0030 0.8023 0.0005
BT-20 GW843682X
0.04
uM
LJP6
 0.8628 0.0329 0.8027 0.0443
BT-20 HG-5-113-01
0.04
uM
LJP5
 0.9780 0.0218 0.9673 0.0315
BT-20 HG-5-88-01
0.04
uM
LJP6
 0.7841 0.0303 0.6860 0.0482
BT-20 Imatinib
0.04
uM
LJP6
 0.9851 0.0102 0.9778 0.0155
BT-20 JNK-9L
0.04
uM
LJP6
 0.8325 0.0281 0.7588 0.0365
BT-20 JW-7-24-1
0.04
uM
LJP6
 0.8209 0.0238 0.7405 0.0345
BT-20 Lapatinib
0.04
uM
LJP6
 0.8658 0.0463 0.8074 0.0635
BT-20 LDN-193189
0.04
uM
LJP5
 1.0114 0.0179 1.0173 0.0266
BT-20 Linifanib
0.04
uM
LJP6
 1.0575 0.0063 1.0834 0.0091
BT-20 Linsitinib
0.04
uM
LJP5
 0.8837 0.0140 0.8309 0.0222
BT-20 Mitoxantrone
0.04
uM
LJP5
 0.4318 0.0400 0.1760 0.0639
BT-20 Mitoxantrone
0.04
uM
LJP6
 0.4777 0.0555 0.2459 0.0674
BT-20 MK2206
0.04
uM
LJP6
 0.9582 0.0449 0.9417 0.0640
BT-20 Neratinib
0.04
uM
LJP5
 0.7898 0.0160 0.6953 0.0241
BT-20 Nilotinib
0.04
uM
LJP5
 1.0196 0.0233 1.0285 0.0333
BT-20 Nintedanib
0.04
uM
LJP6
 1.0015 0.0292 1.0030 0.0416
BT-20 NU7441
0.04
uM
LJP5
 1.0674 0.0147 1.0976 0.0206
BT-20 Dactolisib
0.04
uM
LJP5
 0.4567 0.0437 0.2143 0.0533
BT-20 NVP-TAE684
0.04
uM
LJP6
 1.0100 0.0088 1.0150 0.0133
BT-20 Palbociclib
0.04
uM
LJP6
 0.7153 0.0376 0.5892 0.0476